HBOT is FDA Approved
In the United States, Hyperbaric Oxygen Therapy (HBOT) is approved by the FDA for 14 accepted indications taking guidance from the Undersea and Hyperbaric Medical Society (UHMS). However, internationally HBOT is indicated for many more conditions including those listed below. These international indications are supported by strong scientific research and clinical evidence that provide very robust substantiation for their use in these conditions. In some cases the international evidence provides more compelling validation than that used to support the 14 accepted indications used in the United States. These internationally accepted indications are treated as "off label" use in the United States. It is common and legal for physicians to prescribe FDA approved devices and drugs for "off label" uses. These "off label" uses have contributed to the mounting evidence that off label use of HBOT has great merit, especially for those conditions that have international acceptance. There are many common uses of off label drugs and devices in the United States. FDA approved drugs and devices are routinely used off label in doctor's offices and hospitals across the country. Similarly the use of HBOT for internationally accepted indications is an accepted "off label" use of Hyperbaric Oxygen Therapy in the USA.
Hyperbaric Oxygen Therapy (HBOT) is a method of administering pure oxygen at greater than atmospheric pressure to a patient in order to improve or correct certain conditions.
The air we normally breathe is 21% oxygen and at the atmospheric pressure in which we live (1 ATA), this oxygen is almost exclusively carried by the red blood cells. During HBOT, when pure oxygen is administered at greater than atmospheric pressure, there is a substantial increase in the amount of oxygen carried in all body fluids including plasma, cerebrospinal fluid surrounding the brain and spinal cord, lymph and intracellular fluids. This allows increased oxygen levels even in areas with poor or compromised blood supply as well as in areas of tissue damage.
Hyperbaric Oxygen Therapy (HBOT) is a method of administering pure oxygen at greater than atmospheric pressure to a patient in order to improve or correct certain conditions.
The air we normally breathe is 21% oxygen and at the atmospheric pressure in which we live (1 ATA), this oxygen is almost exclusively carried by the red blood cells. During HBOT, when pure oxygen is administered at greater than atmospheric pressure, there is a substantial increase in the amount of oxygen carried in all body fluids including plasma, cerebrospinal fluid surrounding the brain and spinal cord, lymph and intracellular fluids. This allows increased oxygen levels even in areas with poor or compromised blood supply as well as in areas of tissue damage.